Darunavir and Hypertriglyceridaemia - a phase IV clinical study of FDA data

Summary:

Hypertriglyceridaemia is reported as a side effect among people who take Darunavir (darunavir), especially for people who are male, 30-39 old, have been taking the drug for 2 - 5 years also take Emtriva, and have Hiv infection.

The phase IV clinical study analyzes which people have Hypertriglyceridaemia when taking Darunavir. It is created by eHealthMe based on reports of 6,478 people who have side effects when taking Darunavir from the FDA, and is updated regularly.

What is Darunavir?

Darunavir has active ingredients of darunavir. eHealthMe is studying from 6,483 Darunavir users. Check the latest studies of Darunavir.

What is Hypertriglyceridaemia?

Hypertriglyceridaemia (excess of triglycerides in the blood) is found to be associated with 772 drugs and 757 conditions by eHealthMe. Check the latest studies of Hypertriglyceridaemia.

On Apr, 25, 2026

6,478 people reported to have side effects when taking Darunavir.
Among them, 37 people (0.57%) have Hypertriglyceridaemia.

Could Darunavir cause Hypertriglyceridaemia?

Among these 37 people:

How long have people been on Darunavir when they have Hypertriglyceridaemia? *

What is the gender of people who have Hypertriglyceridaemia when taking Darunavir? *

female: 0.0 %
male: 100 %

What is the age of people who have Hypertriglyceridaemia when taking Darunavir? *

What are other drugs people take besides Darunavir? *

What are other side effects people have besides Hypertriglyceridaemia? *

Acute Myocardial Infarction (acute heart attack): 20 people, 54.05%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 20 people, 54.05%
Heart Attack: 13 people, 35.14%
Hepatic Function Abnormal: 5 people, 13.51%
Renal Disorder (kidney disease): 4 people, 10.81%
Syphilis (sexually transmitted , chronic bacterial disease caused by the spirochete treponema pallidum): 3 people, 8.11%
Folliculitis (infection of hair root): 3 people, 8.11%
White Blood Cell Count Decreased: 2 people, 5.41%
High Blood Pressure: 2 people, 5.41%
Dyslipidaemia (abnormal amount of lipids): 2 people, 5.41%

What are the existing conditions these people have? *

Hiv Infection: 33 people, 89.19%
Dyslipidaemia (abnormal amount of lipids): 5 people, 13.51%
High Blood Pressure: 5 people, 13.51%
Syphilis (sexually transmitted , chronic bacterial disease caused by the spirochete treponema pallidum): 3 people, 8.11%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 8.11%
Hyperchlorhydria (gastric acid levels are higher in stomach): 2 people, 5.41%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 5.41%
Blood Pressure Abnormal: 2 people, 5.41%
Folliculitis (infection of hair root): 2 people, 5.41%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Darunavir and have Hypertriglyceridaemia?

- Check whether Hypertriglyceridaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Darunavir:

Darunavir (6,483 reports)

Browse all side effects of Darunavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypertriglyceridaemia:

Hypertriglyceridaemia (772 drugs)

Browse all the conditions that are associated with Hypertriglyceridaemia:

Hypertriglyceridaemia (757 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on darunavir (the active ingredients of Darunavir) and Darunavir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.